Last reviewed · How we verify
Sustained Release d-Amphetamine
At a glance
| Generic name | Sustained Release d-Amphetamine |
|---|---|
| Also known as | Dexedrine Spansule SR |
| Sponsor | Joshua A. Lile, Ph.D. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Targeting Anhedonia in Cocaine Use Disorder (PHASE2)
- Impact of Sustained Release d-Amphetamine on Choice Between Cocaine and a Non-Drug Reinforcer (EARLY_PHASE1)
- Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals (PHASE2)
- Sustained Release d-Amphetamine & Buprenorphine on Drug Seeking Behavior in Opioid & Cocaine Dependent Individuals
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |